Pregnant women with covid-19 are at greater risk of severe disease than their non-pregnant
peers, and yet they are frequently denied investigations or treatments because of unfounded …

Population-level data on COVID-19 vaccine uptake in pregnancy and SARS-CoV-2 infection
outcomes are lacking. We describe COVID-19 vaccine uptake and SARS-CoV-2 infection in …

Background Evidence suggests that the SARS-CoV-2 omicron (B. 1· 1.529) is associated
with lower risks of adverse outcomes than the delta (B. 1.617. 2) variant among the general …

Data on the safety of COVID-19 vaccines in early pregnancy are limited. We conducted a
national, population-based, matched cohort study assessing associations between COVID …

Evidence on associations between COVID-19 vaccination or SARS-CoV-2 infection and the
risk of congenital anomalies is limited. Here we report a national, population-based …

Understanding the impact of SARS-CoV-2 infection and COVID-19 vaccination in pregnancy
on neonatal and maternal outcomes informs clinical decision-making. Here we report a …

Background Vaccination continues to be the key public health measure for preventing
severe COVID-19 outcomes. Certain groups may be at higher risk of incomplete vaccine …

Objectives To examine neonates in Scotland aged 0–27 days with SARS-CoV-2 infection
confirmed by viral testing; the risk of confirmed neonatal infection by maternal and infant …

A critical factor in infectious disease control is the risk of an outbreak overwhelming local
healthcare capacity. The overall demand on healthcare services will depend on disease …

Methods SLiPBD comprises a population-based e-cohort of all fetuses and births (babies)
from pregnancies to women in Scotland from 2000 onwards. It is updated monthly by linking …